{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Eradicating Hepatitis C Virus: The APRN's Role

Activity Steps

Purpose of Activity

To provide information that supports the APRN's role in the eradication of hepatitis C virus (HCV).

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Recognize the demographics of HCV infection indicating high risk populations.
  2. Examine methods of screening and diagnosing hepatitis C virus.
  3. Identify treatment regimens for hepatitis C virus and implications for patient education.
Price: $17.95


  • ANCC 1.5 CH / 1.0 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours

Test Code: NP1119B
Published: Nov 2019
Expires: 9/3/2021
Required Passing Score: 13/18 (72%)
Authors: Renee Pozza, PhD, RN, FNP-BC, FAASLD; Catherine McCoy-Hill, DNP, CCRN, ANP; Katherine Hall, PhD, RN, FNP-BC; Anna Hefner, PhD, RN, CPNP; Kimberly Wilgers, BS, CMA; Julia Tapelband, BS, EMT; Momin Masroor, BS, EMT; Tarek Hassanein, MD, FACP, FACG, AGAF, FAASLD